Experimental cancer therapy shows success in more than 70% of patients in global clinical trials

A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical trials, according to researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.

source https://medicalxpress.com/news/2022-12-experimental-cancer-therapy-success-patients.html